170 related articles for article (PubMed ID: 38454442)
41. The FBXW7 tumor suppressor inhibits breast cancer proliferation and promotes apoptosis by targeting MTDH for degradation.
Chen X; Li XY; Long M; Wang X; Gao ZW; Cui Y; Ren J; Zhang Z; Liu C; Dong K; Zhang H
Neoplasma; 2018; 65(2):201-209. PubMed ID: 29534580
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of FAM83D gene expression across human cancer types.
Walian PJ; Hang B; Mao JH
Oncotarget; 2016 Jan; 7(3):3332-40. PubMed ID: 26678035
[TBL] [Abstract][Full Text] [Related]
43. FBXW7-mediated stability regulation of signal transducer and activator of transcription 2 in melanoma formation.
Lee CJ; An HJ; Kim SM; Yoo SM; Park J; Lee GE; Kim WY; Kim DJ; Kang HC; Lee JY; Lee HS; Cho SJ; Cho YY
Proc Natl Acad Sci U S A; 2020 Jan; 117(1):584-594. PubMed ID: 31843895
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
Gong J; Cui Z; Li L; Ma Q; Wang Q; Gao Y; Sun H
Tumour Biol; 2015 Sep; 36(10):7831-40. PubMed ID: 25944166
[TBL] [Abstract][Full Text] [Related]
45. FBXW7 in breast cancer: mechanism of action and therapeutic potential.
Chen S; Leng P; Guo J; Zhou H
J Exp Clin Cancer Res; 2023 Sep; 42(1):226. PubMed ID: 37658431
[TBL] [Abstract][Full Text] [Related]
46. Fbxw7 suppresses carcinogenesis and stemness in triple-negative breast cancer through CHD4 degradation and Wnt/β-catenin pathway inhibition.
Xiao G; Lu W; Yuan J; Liu Z; Wang P; Fan H
J Transl Med; 2024 Jan; 22(1):99. PubMed ID: 38268032
[TBL] [Abstract][Full Text] [Related]
47. E3 ubiquitin ligase FBXW7 enhances radiosensitivity of non-small cell lung cancer cells by inhibiting SOX9 regulation of CDKN1A through ubiquitination.
Zhu H; Wang X; Zhou X; Lu S; Gu G; Liu C
Lab Invest; 2022 Nov; 102(11):1203-1213. PubMed ID: 35840806
[TBL] [Abstract][Full Text] [Related]
48. Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation.
Koo J; Wu X; Mao Z; Khuri FR; Sun SY
J Biol Chem; 2015 May; 290(22):14120-9. PubMed ID: 25897075
[TBL] [Abstract][Full Text] [Related]
49. miR-367 promotes tumor growth by inhibiting FBXW7 in NSCLC.
Xiao G; Gao X; Sun X; Yang C; Zhang B; Sun R; Huang G; Li X; Liu J; Du N; Liu D; Liang R; Ren H; Qin S
Oncol Rep; 2017 Aug; 38(2):1190-1198. PubMed ID: 28656290
[TBL] [Abstract][Full Text] [Related]
50. TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis.
Zhang G; Zhu Q; Fu G; Hou J; Hu X; Cao J; Peng W; Wang X; Chen F; Cui H
Br J Cancer; 2019 Dec; 121(12):1069-1078. PubMed ID: 31740732
[TBL] [Abstract][Full Text] [Related]
51. FBXW7: a critical tumor suppressor of human cancers.
Yeh CH; Bellon M; Nicot C
Mol Cancer; 2018 Aug; 17(1):115. PubMed ID: 30086763
[TBL] [Abstract][Full Text] [Related]
52. MiR-25 is up-regulated in non-small cell lung cancer and promotes cell proliferation and motility by targeting FBXW7.
Xiang J; Hang JB; Che JM; Li HC
Int J Clin Exp Pathol; 2015; 8(8):9147-53. PubMed ID: 26464659
[TBL] [Abstract][Full Text] [Related]
53. Clinical significance of FBXW7 loss of function in human cancers.
Fan J; Bellon M; Ju M; Zhao L; Wei M; Fu L; Nicot C
Mol Cancer; 2022 Mar; 21(1):87. PubMed ID: 35346215
[TBL] [Abstract][Full Text] [Related]
54. Loss of FBXW7-mediated degradation of BRAF elicits resistance to BET inhibitors in adult T cell leukemia cells.
Yeh CH; Bellon M; Wang F; Zhang H; Fu L; Nicot C
Mol Cancer; 2020 Sep; 19(1):139. PubMed ID: 32907612
[TBL] [Abstract][Full Text] [Related]
55. FBXW7 inhibits the progression of ESCC by directly inhibiting the stemness of tumor cells.
Bi Y; Yang Y; Zhang Y; Cheng C; Tang P; Xiao H; Yuan F; Wu W; Yang B
Neoplasma; 2023 Dec; 70(6):733-746. PubMed ID: 38014700
[TBL] [Abstract][Full Text] [Related]
56. FAM83D activates the MEK/ERK signaling pathway and promotes cell proliferation in hepatocellular carcinoma.
Wang D; Han S; Peng R; Wang X; Yang XX; Yang RJ; Jiao CY; Ding D; Ji GW; Li XC
Biochem Biophys Res Commun; 2015 Mar; 458(2):313-20. PubMed ID: 25646692
[TBL] [Abstract][Full Text] [Related]
57. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E.
Tu K; Zheng X; Zhou Z; Li C; Zhang J; Gao J; Yao Y; Liu Q
PLoS One; 2013; 8(7):e68574. PubMed ID: 23840897
[TBL] [Abstract][Full Text] [Related]
58. The promotional effect of microRNA-103a-3p in cervical cancer cells by regulating the ubiquitin ligase FBXW7 function.
Ren L; Yang J; Meng X; Zhang J; Zhang Y
Hum Cell; 2022 Mar; 35(2):472-485. PubMed ID: 35094292
[TBL] [Abstract][Full Text] [Related]
59. Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Zheng Y; Song A; Wang C; Zhang W; Liang D; Ding X; Li G; Zhang H; Zhang W; Du Y; Zhou J; Wu H; Wu Y; Song X
Cell Death Dis; 2020 Aug; 11(8):615. PubMed ID: 32792479
[TBL] [Abstract][Full Text] [Related]
60. The anti-angiogenesis role of FBXW7 in diabetic retinopathy by facilitating the ubiquitination degradation of c-Myc to orchestrate the HDAC2.
Hu L; Lv X; Li D; Zhang W; Ran G; Li Q; Hu J
J Cell Mol Med; 2021 Feb; 25(4):2190-2202. PubMed ID: 33369138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
